IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SALIL KATHPALIA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1295875714
CMS profile
286083
Location
NEWBURGH, NY

General Payments · PY2018–2024

$4,141.77

  • Reported across 225 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,189.34

52 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,077.85 51
Education $111.49 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $356.89 13
ABBVIE INC. $262.99 12
Axsome Therapeutics, Inc. $222.77 7
ITI, Inc. $168.09 10
Neurocrine BioSciences, Inc. $77.86 4
Otsuka America Pharmaceutical, Inc. $63.68 4
Takeda Pharmaceuticals U.S.A., Inc. $37.06 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,340.74 90
PY2019 $901.77 49
PY2020 $107.28 8
PY2023 $602.64 26
PY2024 $1,189.34 52

Payment records · PY2024 (52)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920202023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.56 01/08/2024 Food and Beverage Undisputed 01/23/2026 1104038478 CMS
ABBVIE INC. $33.02 01/19/2024 Food and Beverage Undisputed 01/23/2026 1104038480 CMS
ABBVIE INC. $23.76 01/26/2024 Food and Beverage Undisputed 01/23/2026 1104038482 CMS
ABBVIE INC. $17.44 02/26/2024 Food and Beverage Undisputed 01/23/2026 1104038484 CMS
ABBVIE INC. $22.91 03/08/2024 Food and Beverage Undisputed 01/23/2026 1104038486 CMS
ABBVIE INC. $15.24 03/22/2024 Food and Beverage Undisputed 01/23/2026 1104038488 CMS
ABBVIE INC. $26.29 04/05/2024 Food and Beverage Undisputed 01/23/2026 1104038490 CMS
ABBVIE INC. $24.93 04/26/2024 Food and Beverage Undisputed 01/23/2026 1104038492 CMS
ABBVIE INC. $21.63 05/31/2024 Food and Beverage Undisputed 01/23/2026 1104038494 CMS
ABBVIE INC. $22.13 08/12/2024 Food and Beverage Undisputed 01/23/2026 1104038496 CMS
ABBVIE INC. $23.06 09/09/2024 Food and Beverage Undisputed 01/23/2026 1104038498 CMS
ABBVIE INC. $14.02 10/11/2024 Food and Beverage Undisputed 01/23/2026 1104038500 CMS
Axsome Therapeutics, Inc. $17.12 02/02/2024 Food and Beverage Undisputed 01/23/2026 1148318332 CMS
Axsome Therapeutics, Inc. $15.87 03/22/2024 Food and Beverage Undisputed 01/23/2026 1148318334 CMS
Axsome Therapeutics, Inc. $117.07 03/26/2024 Food and Beverage Undisputed 01/23/2026 1148318342 CMS
Axsome Therapeutics, Inc. $24.91 04/15/2024 Food and Beverage Undisputed 01/23/2026 1148318336 CMS
Axsome Therapeutics, Inc. $13.65 05/17/2024 Food and Beverage Undisputed 01/23/2026 1148318338 CMS
Axsome Therapeutics, Inc. $16.51 07/05/2024 Food and Beverage Undisputed 01/23/2026 1148318340 CMS
Axsome Therapeutics, Inc. $17.64 12/13/2024 Food and Beverage Undisputed 01/23/2026 1148318344 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.57 02/01/2024 Food and Beverage Undisputed 01/23/2026 1143254492 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.79 02/23/2024 Food and Beverage Undisputed 01/23/2026 1143254496 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.87 03/11/2024 Food and Beverage Undisputed 01/23/2026 1143254499 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.83 04/19/2024 Food and Beverage Undisputed 01/23/2026 1143254503 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8.45 06/03/2024 Food and Beverage Undisputed 01/23/2026 1143254507 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.71 09/27/2024 Food and Beverage Undisputed 01/23/2026 1143254510 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.23 10/18/2024 Food and Beverage Undisputed 01/23/2026 1143254514 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.36 10/24/2024 Food and Beverage Undisputed 01/23/2026 1143254518 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.22 10/28/2024 Food and Beverage Undisputed 01/23/2026 1143254521 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.06 12/06/2024 Food and Beverage Undisputed 01/23/2026 1143254525 CMS
Neurocrine Biosciences, Inc. $22.05 03/01/2024 Food and Beverage Undisputed 01/23/2026 1150851056 CMS
Neurocrine Biosciences, Inc. $16.79 06/17/2024 Food and Beverage Undisputed 01/23/2026 1150869688 CMS
Neurocrine Biosciences, Inc. $16.82 09/16/2024 Food and Beverage Undisputed 01/23/2026 1150869588 CMS
Neurocrine Biosciences, Inc. $22.20 11/11/2024 Food and Beverage Undisputed 01/23/2026 1150850564 CMS
Otsuka America Pharmaceutical, Inc. $18.26 04/12/2024 Food and Beverage Undisputed 01/23/2026 1118919332 CMS
Otsuka America Pharmaceutical, Inc. $18.64 04/29/2024 Food and Beverage Undisputed 01/23/2026 1118919334 CMS
Otsuka America Pharmaceutical, Inc. $13.61 07/29/2024 Food and Beverage Undisputed 01/23/2026 1118919336 CMS
Otsuka America Pharmaceutical, Inc. $13.17 08/05/2024 Food and Beverage Undisputed 01/23/2026 1118919338 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.97 05/06/2024 Food and Beverage Undisputed 01/23/2026 1137596453 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.09 07/12/2024 Food and Beverage Undisputed 01/23/2026 1137596457 CMS
Teva Pharmaceuticals USA, Inc. $21.69 01/26/2024 Food and Beverage Undisputed 01/23/2026 1151736877 CMS
Teva Pharmaceuticals USA, Inc. $15.89 02/16/2024 Food and Beverage Undisputed 01/23/2026 1151736879 CMS
Teva Pharmaceuticals USA, Inc. $19.94 03/29/2024 Food and Beverage Undisputed 01/23/2026 1151736911 CMS
Teva Pharmaceuticals USA, Inc. $111.49 04/30/2024 Education Undisputed 01/23/2026 1151736981 CMS
Teva Pharmaceuticals USA, Inc. $21.41 05/20/2024 Food and Beverage Undisputed 01/23/2026 1151736929 CMS
Teva Pharmaceuticals USA, Inc. $24.38 06/13/2024 Food and Beverage Undisputed 01/23/2026 1151736941 CMS
Teva Pharmaceuticals USA, Inc. $7.43 08/26/2024 Food and Beverage Undisputed 01/23/2026 1151736977 CMS
Teva Pharmaceuticals USA, Inc. $25.42 09/20/2024 Food and Beverage Undisputed 01/23/2026 1151736993 CMS
Teva Pharmaceuticals USA, Inc. $18.45 10/25/2024 Food and Beverage Undisputed 01/23/2026 1151737015 CMS
Teva Pharmaceuticals USA, Inc. $28.36 10/31/2024 Food and Beverage Undisputed 01/23/2026 1151737025 CMS
Teva Pharmaceuticals USA, Inc. $17.87 12/02/2024 Food and Beverage Undisputed 01/23/2026 1151737039 CMS
Teva Pharmaceuticals USA, Inc. $21.37 12/20/2024 Food and Beverage Undisputed 01/23/2026 1151737041 CMS
Teva Pharmaceuticals USA, Inc. $23.19 12/27/2024 Food and Beverage Undisputed 01/23/2026 1151737043 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.